Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells

a technology of restricted progenitor cells and compositions, which is applied in the field of methods and compositions for expanding, identifying, characterizing and enhancing the potency of mammalian-derived glial restricted progenitor cells, can solve the problems of reducing the number of glial scar formation, the inability of demyelinated neurons to properly conduct signals, and the inability to develop products that can help restore lost function, so as to reduce the formation of glial scars

Inactive Publication Date: 2019-01-31
Q THERAPEUTICS
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Demyelinated neurons cannot properly conduct signals and eventually will die.
However, the majority of patients who experience demyelination due to various diseases or trauma do not experience sufficient endogenous remyelination (Prineas et al., Ann. Neurol. 1993 33:137-151), and despite much need and effort, little progress has been made in developing products that can help restore lost function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
  • Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells
  • Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021]The present invention provides methods for manufacturing mammalian glial progenitor cells (GRPs). GRPs are also referred to as glial restricted precursor cells or glial progenitor cells in the literature.

[0022]Mammalian GRP cells of the present invention can be derived from any mammalian tissue source capable of generating A2B5 positive cells. Examples of such mammalian tissue sources include, without limitation, embryonic / fetal, and adult (inclusive of all ages after birth) sources, all from tissues including, but not limited to neural, brain, spinal cord, optic nerve, olfactory epithelium, endocrine, skin, muscle, fat, connective, placental, cord blood, blood, bone marrow, bone, embryonic stem cells, and induced pluripotent cells. By capable of generating A2B5 positive cells it is meant to include mammalian tissue sources differentiated into A2B5 positive cells, mammalian tissue sources de-differentiated into A2B5 positive cells, as well as mammalian tissue sources de-differ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to View More

Abstract

Methods for producing a population of human-derived glial restricted progenitor cells (GRPs) with decreased potentially unintended or undesired cellular phenotypes and / or decreased standard deviation in the cells of the population are provided. Also provided are antibody panels and gene expression profiles to characterize GRPs and a method for its use in characterizing GRP cells. In addition methods for use of these GRP cells to generate astrocytes and / or oligodendrocytes, to re-myelinate neurons and to treat glial cell related and other neurodegenerative diseases or disorders or injuries or damage to the nervous system are provided. A method to manufacture neural cells depleted of A2B5 positive cells is also provided.

Description

[0001]This patent application is a continuation of U.S. Ser. No. 13 / 508,803 filed May 9, 2012, which is the National Stage of International Application No. PCT / US2010 / 055956, filed Nov. 9, 2010, which claims the benefit of priority from U.S. Provisional Application Ser. No. 61 / 326,799, filed Apr. 22, 2010 and U.S. Provisional Application Ser. No. 61 / 260,441, filed Nov. 12, 2009, teachings of each of which are herein incorporated by reference in their entireties.INTRODUCTIONField of the Invention[0002]The present invention provides manufacturing methods for a population of mammalian-derived glial restricted progenitor cells (GRPs) with decreased potentially unintended cellular phenotypes and / or decreased standard deviation in the cells of the population as well as methods for use of these cells. Also provided in the present invention is an antibody panel to characterize GRPs and a method for its use in characterizing GRP cells.Background of the Invention[0003]Glial restricted progeni...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/079
CPCC12N5/0622A61K35/30C07K16/18C12N5/0081C12N5/0602C12N5/0618C12N5/0623G01N33/56966A61P25/00A61P25/28A61P43/00
Inventor SANDROCK, ROBERTCAMPANELLI, JAMESEPPSTEIN, DEBORAH
Owner Q THERAPEUTICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com